The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
0597-10-HMO
Observational Cohort Study- The Clinical and Laboratory Characteristics of Recurrent Drug- Related
2 other identifiers
observational
500
1 country
2
Brief Summary
The aim of this study is to identify factors associated with hyponatremia among patients hospitalized in the internal medicine ward. Consequtive patients hospitalized because of hyponatremia will be recruited. Follow up will include clinical factors such as background diseases, complete drug history, blood tests including Biochemistry tests (Sodium, renal function), endocrinological evaluation, thyroid function tests, cortisol,urinary sodium on addmition. One month following discharge follow up Sodium level will be taken.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2012
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2012
CompletedFirst Posted
Study publicly available on registry
January 12, 2012
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedJanuary 12, 2012
January 1, 2012
2.9 years
January 10, 2012
January 10, 2012
Conditions
Eligibility Criteria
Consequtive patients hospitalized to the internal medicine ward due to hyponatremia
You may qualify if:
- patients hospitalized to the internal medicine ward due to hyponatremia
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hadassah- Hebrew-University Medical Center
Jerusalem, 91120, Israel
Hadassah-Hebrew University Medical Center
Jerusalem, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mordechai Muszkat, MD
Hadassah Medical Organization
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2012
First Posted
January 12, 2012
Study Start
February 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2017
Last Updated
January 12, 2012
Record last verified: 2012-01